These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

243 related items for PubMed ID: 33384694

  • 1. Factor H Autoantibodies and Complement-Mediated Diseases.
    Zhang Y, Ghiringhelli Borsa N, Shao D, Dopler A, Jones MB, Meyer NC, Pitcher GR, Taylor AO, Nester CM, Schmidt CQ, Smith RJH.
    Front Immunol; 2020; 11():607211. PubMed ID: 33384694
    [Abstract] [Full Text] [Related]

  • 2. Factor H autoantibodies and deletion of Complement Factor H-Related protein-1 in rheumatic diseases in comparison to atypical hemolytic uremic syndrome.
    Foltyn Zadura A, Zipfel PF, Bokarewa MI, Sturfelt G, Jönsen A, Nilsson SC, Hillarp A, Saxne T, Trouw LA, Blom AM.
    Arthritis Res Ther; 2012 Aug 15; 14(4):R185. PubMed ID: 22894814
    [Abstract] [Full Text] [Related]

  • 3. Anti-factor H autoantibodies in C3 glomerulopathies and in atypical hemolytic uremic syndrome: one target, two diseases.
    Blanc C, Togarsimalemath SK, Chauvet S, Le Quintrec M, Moulin B, Buchler M, Jokiranta TS, Roumenina LT, Fremeaux-Bacchi V, Dragon-Durey MA.
    J Immunol; 2015 Jun 01; 194(11):5129-38. PubMed ID: 25917093
    [Abstract] [Full Text] [Related]

  • 4. Complete functional characterization of disease-associated genetic variants in the complement factor H gene.
    Merinero HM, García SP, García-Fernández J, Arjona E, Tortajada A, Rodríguez de Córdoba S.
    Kidney Int; 2018 Feb 01; 93(2):470-481. PubMed ID: 28941939
    [Abstract] [Full Text] [Related]

  • 5. Complement factor H, FHR-3 and FHR-1 variants associate in an extended haplotype conferring increased risk of atypical hemolytic uremic syndrome.
    Bernabéu-Herrero ME, Jiménez-Alcázar M, Anter J, Pinto S, Sánchez Chinchilla D, Garrido S, López-Trascasa M, Rodríguez de Córdoba S, Sánchez-Corral P.
    Mol Immunol; 2015 Oct 01; 67(2 Pt B):276-86. PubMed ID: 26163426
    [Abstract] [Full Text] [Related]

  • 6. Overactivity of Alternative Pathway Convertases in Patients With Complement-Mediated Renal Diseases.
    Michels MAHM, van de Kar NCAJ, Okrój M, Blom AM, van Kraaij SAW, Volokhina EB, van den Heuvel LPWJ.
    Front Immunol; 2018 Oct 01; 9():612. PubMed ID: 29670616
    [Abstract] [Full Text] [Related]

  • 7. Case Report: Severe Complement-Mediated Thrombotic Microangiopathy in IgG4-Related Disease Secondary to Anti-Factor H IgG4 Autoantibodies.
    Breville G, Zamberg I, Sadallah S, Stephan C, Ponte B, Seebach JD.
    Front Immunol; 2020 Oct 01; 11():604759. PubMed ID: 33643292
    [Abstract] [Full Text] [Related]

  • 8. The major autoantibody epitope on factor H in atypical hemolytic uremic syndrome is structurally different from its homologous site in factor H-related protein 1, supporting a novel model for induction of autoimmunity in this disease.
    Bhattacharjee A, Reuter S, Trojnár E, Kolodziejczyk R, Seeberger H, Hyvärinen S, Uzonyi B, Szilágyi Á, Prohászka Z, Goldman A, Józsi M, Jokiranta TS.
    J Biol Chem; 2015 Apr 10; 290(15):9500-10. PubMed ID: 25659429
    [Abstract] [Full Text] [Related]

  • 9. IgM Autoantibodies to Complement Factor H in Atypical Hemolytic Uremic Syndrome.
    Cugno M, Berra S, Depetri F, Tedeschi S, Griffini S, Grovetti E, Caccia S, Cresseri D, Messa P, Testa S, Giglio F, Peyvandi F, Ardissino G.
    J Am Soc Nephrol; 2021 May 03; 32(5):1227-1235. PubMed ID: 33712527
    [Abstract] [Full Text] [Related]

  • 10. Characterization of complement factor H-related (CFHR) proteins in plasma reveals novel genetic variations of CFHR1 associated with atypical hemolytic uremic syndrome.
    Abarrategui-Garrido C, Martínez-Barricarte R, López-Trascasa M, de Córdoba SR, Sánchez-Corral P.
    Blood; 2009 Nov 05; 114(19):4261-71. PubMed ID: 19745068
    [Abstract] [Full Text] [Related]

  • 11. Complement factor H-related protein 1 deficiency and factor H antibodies in pediatric patients with atypical hemolytic uremic syndrome.
    Hofer J, Janecke AR, Zimmerhackl LB, Riedl M, Rosales A, Giner T, Cortina G, Haindl CJ, Petzelberger B, Pawlik M, Jeller V, Vester U, Gadner B, van Husen M, Moritz ML, Würzner R, Jungraithmayr T, German-Austrian HUS Study Group.
    Clin J Am Soc Nephrol; 2013 Mar 05; 8(3):407-15. PubMed ID: 23243267
    [Abstract] [Full Text] [Related]

  • 12. Rare Functional Variants in Complement Genes and Anti-FH Autoantibodies-Associated aHUS.
    Valoti E, Alberti M, Iatropoulos P, Piras R, Mele C, Breno M, Cremaschi A, Bresin E, Donadelli R, Alizzi S, Amoroso A, Benigni A, Remuzzi G, Noris M.
    Front Immunol; 2019 Mar 05; 10():853. PubMed ID: 31118930
    [Abstract] [Full Text] [Related]

  • 13. Factor H autoantibody is associated with atypical hemolytic uremic syndrome in children in the United Kingdom and Ireland.
    Brocklebank V, Johnson S, Sheerin TP, Marks SD, Gilbert RD, Tyerman K, Kinoshita M, Awan A, Kaur A, Webb N, Hegde S, Finlay E, Fitzpatrick M, Walsh PR, Wong EKS, Booth C, Kerecuk L, Salama AD, Almond M, Inward C, Goodship TH, Sheerin NS, Marchbank KJ, Kavanagh D.
    Kidney Int; 2017 Nov 05; 92(5):1261-1271. PubMed ID: 28750931
    [Abstract] [Full Text] [Related]

  • 14. Heterogeneity but individual constancy of epitopes, isotypes and avidity of factor H autoantibodies in atypical hemolytic uremic syndrome.
    Nozal P, Bernabéu-Herrero ME, Uzonyi B, Szilágyi Á, Hyvärinen S, Prohászka Z, Jokiranta TS, Sánchez-Corral P, López-Trascasa M, Józsi M.
    Mol Immunol; 2016 Feb 05; 70():47-55. PubMed ID: 26703217
    [Abstract] [Full Text] [Related]

  • 15. Differential contribution of C5aR and C5b-9 pathways to renal thrombic microangiopathy and macrovascular thrombosis in mice carrying an atypical hemolytic syndrome-related factor H mutation.
    Ueda Y, Miwa T, Ito D, Kim H, Sato S, Gullipalli D, Zhou L, Golla M, Song D, Dunaief JL, Palmer MB, Song WC.
    Kidney Int; 2019 Jul 05; 96(1):67-79. PubMed ID: 30910380
    [Abstract] [Full Text] [Related]

  • 16. Anti-complement-factor H-associated glomerulopathies.
    Durey MA, Sinha A, Togarsimalemath SK, Bagga A.
    Nat Rev Nephrol; 2016 Sep 05; 12(9):563-78. PubMed ID: 27452363
    [Abstract] [Full Text] [Related]

  • 17. Complement Factor I Variants in Complement-Mediated Renal Diseases.
    Zhang Y, Goodfellow RX, Ghiringhelli Borsa N, Dunlop HC, Presti SA, Meyer NC, Shao D, Roberts SM, Jones MB, Pitcher GR, Taylor AO, Nester CM, Smith RJH.
    Front Immunol; 2022 Sep 05; 13():866330. PubMed ID: 35619721
    [Abstract] [Full Text] [Related]

  • 18. Factor H Competitor Generated by Gene Conversion Events Associates with Atypical Hemolytic Uremic Syndrome.
    Goicoechea de Jorge E, Tortajada A, García SP, Gastoldi S, Merinero HM, García-Fernández J, Arjona E, Cao M, Remuzzi G, Noris M, Rodríguez de Córdoba S.
    J Am Soc Nephrol; 2018 Jan 05; 29(1):240-249. PubMed ID: 28993505
    [Abstract] [Full Text] [Related]

  • 19. High Complement Factor H-Related (FHR)-3 Levels Are Associated With the Atypical Hemolytic-Uremic Syndrome-Risk Allele CFHR3*B.
    Pouw RB, Gómez Delgado I, López Lera A, Rodríguez de Córdoba S, Wouters D, Kuijpers TW, Sánchez-Corral P.
    Front Immunol; 2018 Jan 05; 9():848. PubMed ID: 29740447
    [Abstract] [Full Text] [Related]

  • 20. The high frequency of complement factor H related CFHR1 gene deletion is restricted to specific subgroups of patients with atypical haemolytic uraemic syndrome.
    Dragon-Durey MA, Blanc C, Marliot F, Loirat C, Blouin J, Sautes-Fridman C, Fridman WH, Frémeaux-Bacchi V.
    J Med Genet; 2009 Jul 05; 46(7):447-50. PubMed ID: 19435718
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.